Skip to content
Esta página está disponible en españolCambiar →

SEC filings · updated every 10 minutes

At the SEC on Wednesday, November 18

Wednesday, November 18, 2026 · 152 filings · latest: 20:29 ET

From the companies the site's managers follow: those held by 300+ 13F filers, or 30+ with concentrated managers or well-known investors. Form 144 notices from $1M and insider purchases from $100,000.

Companies with the most concentrated managers that filed that day

Filings of the day

152 filings from 137 companies

  • EquipmentShare.com

    EQPT3 filings
    • 20:29 ET5%+ stakesSEC Schedule 13D/A

      Change in a 5%+ stake with activist intent

      Jabbok Schlacks and 1 related filer updated their stake: 16.3% (41,902,095 shares) (active, 13D) as of November 16, 2026.

      Filed by: Schlacks Jabbok

    • 20:10 ETInsider buyingSEC Form 4 (P)

      Open-market purchase by an insider

      William J. Schlacks (Founder & President) bought 10,000 shares for $145,400 (avg. $14.54).

    • 20:09 ETInsider buyingSEC Form 4 (P)

      Open-market purchase by an insider

      Jabbok Schlacks (Founder & CEO /) bought 16,972 shares for $249,998 (avg. $14.73).

    On GestorLens

    • 4 concentrated managers
    • 165 13F filers
    • 3 insiders bought in 180 days ($4.7M)
    • 1 13D filings in the last year

    Well-known investors: Tiger Global

    GestorLens profile
  • USA Rare Earth

    USAR
    • 20:26 ETInsider buyingSEC Form 4 (P)

      Open-market purchase by an insider

      Michael Blitzer (director) bought 450,000 shares for $3.0 million (avg. $6.66).

    On GestorLens

    • 4 concentrated managers (+2 this quarter)
    • 400 13F filers
    • 2 13D filings in the last year

    Well-known investors: Soros Fund

    GestorLens profile
  • Cerebras Systems

    CBRS3 filings
    • 20:20 ETPlanned insider salesSEC Form 144

      Notice of proposed sale (Form 144)

      Notice of proposed sale: Dhiraj Mallick (officer) may sell up to 18,201 shares (~$1.8 million) on or about November 18, 2026.

    • 20:16 ETPlanned insider salesSEC Form 144

      Notice of proposed sale (Form 144)

      Notice of proposed sale: Sean Lie (officer) may sell up to 30,077 shares (~$2.9 million) on or about November 18, 2026.

    • 20:15 ETPlanned insider salesSEC Form 144

      Notice of proposed sale (Form 144)

      Notice of proposed sale: Andrew D. Feldman (officer, director) may sell up to 37,694 shares (~$3.7 million) on or about November 18, 2026.

    On GestorLens

    • 22 concentrated managers (+2 this quarter)
    • 548 13F filers
    • 1 13D filings in the last year

    Well-known investors: Tiger Global, Dragoneer, Coatue

    GestorLens profile
  • Grindr

    GRND
    • 20:06 ET5%+ stakesSEC Schedule 13D/A

      Change in a 5%+ stake with activist intent

      George Raymond Zage III and 3 related filers updated their stake: 52.6% (92,939,583 shares) (active, 13D) as of November 16, 2026.

      Filed by: Zage George Raymond III

    On GestorLens

    • 3 concentrated managers
    • 184 13F filers
    GestorLens profile
  • Anaptysbio

    ANAB2 filings
    • 19:03 ET5%+ stakesSEC Schedule 13D/A

      Change in a 5%+ stake with activist intent

      EcoR1 Capital and 2 related filers updated their stake: 27.8% (8,254,674 shares) (active, 13D) as of November 16, 2026.

      Filed by: EcoR1 Capital, LLC

    • 18:56 ETInsider buyingSEC Form 4 (P)

      Open-market purchase by an insider

      EcoR1 Capital (director) bought 374,580 shares for $17.2 million (avg. $45.98).

    On GestorLens

    • 7 concentrated managers (+1 this quarter)
    • 228 13F filers
    GestorLens profile
  • Surrozen

    SRZN
    • 18:58 ET5%+ stakesSEC Schedule 13D/A

      Change in a 5%+ stake with activist intent

      Tim Kutzkey and 7 related filers updated their stake: 18.2% (3,813,501 shares) (active, 13D) as of November 16, 2026.

      Filed by: COLUMN GROUP III GP, LP

    On GestorLens

    • 8 concentrated managers (+2 this quarter)
    • 90 13F filers
    • 1 13D filings in the last year
    GestorLens profile
  • Arista Networks

    ANET
    • 17:51 ETPlanned insider salesSEC Form 144

      Notice of proposed sale (Form 144)

      Notice of proposed sale: Andreas Bechtolsheim may sell up to 300,000 shares (~$58.2 million) on or about November 18, 2026.

    On GestorLens

    • 37 concentrated managers (+3 this quarter)
    • 2,371 13F filers

    Well-known investors: Giverny Capital

    GestorLens profile
  • The Boeing

    BA
    • 17:43 ETInsider buyingSEC Form 4 (P)

      Open-market purchase by an insider

      Akhil Johri (director) bought 3,000 shares for $500,067 (avg. $166.69).

    On GestorLens

    • 29 concentrated managers (-3 this quarter)
    • 2,466 13F filers
    • 3 insiders bought in 180 days ($1.8M)

    Well-known investors: David Tepper, Viking Global

    GestorLens profile
  • International Money Express

    IMXI
    • 17:42 ET5%+ stakesSEC Schedule 13D/A

      Change in a 5%+ stake with activist intent

      Magnetar Financial and 3 related filers report a 4.73% stake (1,430,367 shares), below 5% as of November 16, 2026.

      Filed by: Magnetar Financial LLC

    On GestorLens

    • 3 concentrated managers (+1 this quarter)
    • 162 13F filers
    GestorLens profile
  • Aura Minerals

    AUGO
    • 17:42 ETPlanned insider salesSEC Form 144

      Notice of proposed sale (Form 144)

      Notice of proposed sale: Kapitalo Zeta Meridia Master Fundo de Investimento Multimercado may sell up to 49,569 shares (~$1.1 million, 0.06% of shares outstanding) on or about November 18, 2026.

    On GestorLens

    • 4 concentrated managers
    • 235 13F filers
    • 1 insider bought in 180 days ($22.8M)
    GestorLens profile
  • KE Holdings

    BEKE
    • 17:34 ETPlanned insider salesSEC Form 144

      Notice of proposed sale (Form 144)

      Notice of proposed sale: Myriad Talent Investment (officer) may sell up to 500,000 shares (~$9.2 million, 0.05% of shares outstanding) on or about November 18, 2026.

    On GestorLens

    • 5 concentrated managers (-1 this quarter)
    • 214 13F filers
    • 3 13D filings in the last year
    GestorLens profile
  • Kodiak Gas Services

    KGS
    • 17:26 ETInsider buyingSEC Form 4 (P)

      Open-market purchase by an insider

      Randall J Hogan (director) bought 11,500 shares for $493,962 (avg. $42.95).

    On GestorLens

    • 7 concentrated managers (-3 this quarter)
    • 372 13F filers
    • 3 insiders bought in 180 days ($544,115)

    Well-known investors: Lone Pine

    GestorLens profile
  • Sun Life Financial

    SLF
    • 17:26 ETOtherSEC 6-K

      Foreign issuer report

      Company announcement.

      Company headline: “Sunlife redeems Series 2021-1 Subordinated Unsecured”

      From the company's release
      Sun Life Financial Inc. (TSX: SLF) (NYSE: SLF) ("Sunlife") announced today that it completed the redemption of all of its outstanding $500 million principal amount of Series 2021-1 Subordinated Unsecured 2.46% Fixed/Floating Debentures.

    On GestorLens

    • 3 concentrated managers
    • 506 13F filers
    GestorLens profile
  • Tripadvisor

    TRIP
    • 17:23 ET5%+ stakesSEC Schedule 13D

      New 5%+ stake with activist intent

      Pale Fire Capital SICAV a.s. and 4 related filers reported a stake: 7.4% (8,760,345 shares) (active, 13D) as of November 11, 2026.

      Filed by: Pale Fire Capital SE

    On GestorLens

    • 11 concentrated managers (-2 this quarter)
    • 291 13F filers
    • 1 13D filings in the last year

    Well-known investors: Starboard Value

    GestorLens profile
  • Six Flags Entertainment

    FUN
    • 17:20 ETInsider buyingSEC Form 4 (P)

      Open-market purchase by an insider

      Rehan Jaffer (director) bought 550,000 shares for $6.4 million (avg. $11.55).

    On GestorLens

    • 8 concentrated managers
    • 276 13F filers
    • 5 insiders bought in 180 days ($30.5M)
    • 1 13D filings in the last year
    GestorLens profile
  • LuxExperience B.V.

    LUXE
    • 17:18 ETPlanned insider salesSEC Form 144

      Notice of proposed sale (Form 144)

      Notice of proposed sale: Martin Beer (officer) may sell up to 412,116 shares (~$4.9 million, 0.3% of shares outstanding) on or about November 18, 2026.

    On GestorLens

    • 4 concentrated managers
    • 55 13F filers
    GestorLens profile
  • Alamos Gold

    AGI
    • 17:14 ETOtherSEC 6-K

      Foreign issuer report

      Company announcement.

      Company headline: “Toronto, Ontario, Canada M5J 0G3”

      From the company's release
      Alamos Gold Inc. (TSX:AGI; NYSE:AGI) (“Alamos” or the “Company”) has been notified that Newcastle Capital Partners Inc. (“Newcastle”) has made an unsolicited mini-tender offer to purchase up to 2,500,000, or 0.60%, of the outstanding common shares of Alamos at a price of C$40.00 per share.

    On GestorLens

    • 6 concentrated managers (-1 this quarter)
    • 489 13F filers
    GestorLens profile
  • LCI Industries

    LCII
    • 17:12 ETOtherSEC 8-K 8.01

      Other events

      Vote results of the special shareholder meeting held on November 18, 2026.

      Company headline: “Patrick Industries Shareholders and LCI Industries Stockholders Overwhelmingly Approve All-Stock Merger”

      Also: Shareholder vote results

      From the filing
      On November 18, 2026, the Company held a special meeting (the "Special Meeting") of holders of common stock, par value $0.01 per share ("Common Stock"), of the Company at which such holders considered and voted upon (i) the adoption of the Merger Agreement (the "Merger Proposal") and (ii) a non-binding…

    On GestorLens

    • 1 concentrated managers
    • 317 13F filers

    Well-known investors: Soros Fund

    GestorLens profile
  • TEVA Pharmaceutical Industries

    TEVA
    • 17:07 ETLeadership changesSEC 8-K 5.02

      Departure or appointment of directors or officers

      Company headline: “Teva Announces R&D Leadership Transition; Eric Hughes to Depart the Company”

      Also: Regulation FD disclosure

      From the filing
      Departure of Dr. Eric Hughes, Executive Vice President, Global R&D and Chief Medical Officer On November 17, 2026, Dr. Eric Hughes, Executive Vice President, Global R&D and Chief Medical Officer, notified Teva Pharmaceutical Industries Ltd. (“Teva” or the “Company”) of his intention to resign.

    On GestorLens

    • 8 concentrated managers (-1 this quarter)
    • 577 13F filers

    Well-known investors: David Einhorn

    GestorLens profile
  • New Jersey Resources

    NJR
    • 17:07 ETEarningsSEC 8-K 2.02

      Results of operations and financial condition

      Company headline: “NEW JERSEY RESOURCES REPORTS FISCAL 2026 FOURTH-QUARTER AND YEAR-END”

      Also: Regulation FD disclosure

    On GestorLens

    • 2 concentrated managers (-1 this quarter)
    • 444 13F filers
    GestorLens profile
  • CME Group

    CME2 filings
    • 17:06 ETPlanned insider salesSEC Form 144

      Notice of proposed sale (Form 144)

      Notice of proposed sale: Terrence Duffy may sell up to 27,000 shares (~$8.3 million) on or about November 18, 2026.

    • 16:50 ETPlanned insider salesSEC Form 144

      Notice of proposed sale (Form 144)

      Notice of proposed sale: Hilda Piell 1998 TR U/a DTD 04/17/1998 (officer) may sell up to 4,037 shares (~$1.3 million) on or about November 18, 2026.

    On GestorLens

    • 30 concentrated managers (+3 this quarter)
    • 1,758 13F filers

    Well-known investors: Seth Klarman, Soros Fund, Markel Group

    GestorLens profile
  • Kohl’s

    KSS
    • 17:05 ETDividends and buybacksSEC 8-K 8.01

      Dividend announcement

      Quarterly dividend of $0.125 per share, payable December 23, 2026 to shareholders of record on December 9, 2026.

      Company headline: “Kohl’s Corporation Declares Quarterly Dividend”

      From the filing
      On November 18, 2026, the Board of Directors of Kohl's Corporation declared a quarterly cash dividend of $0.125 per share. The dividend will be payable on December 23, 2026, to shareholders of record at the close of business on December 9, 2026.

    On GestorLens

    • 378 13F filers
    GestorLens profile
  • Atlassian

    TEAM
    • 17:05 ETInsider buyingSEC Form 4 (P)

      Open-market purchase by an insider

      Michael Cannon-Brookes (CEO, Co-Founder) bought 13,400 shares for $2.0 million (avg. $146.31).

    On GestorLens

    • 7 concentrated managers (-1 this quarter)
    • 885 13F filers
    • 1 insider bought in 180 days ($8M)

    Well-known investors: Soros Fund

    GestorLens profile
  • Wave Life Sciences

    WVE
    • 17:00 ETLeadership changesSEC 8-K 5.02

      Departure or appointment of directors or officers

      Vote results of the annual shareholder meeting held on November 12, 2026.

      Also: Shareholder vote results

      From the filing
      On November 12, 2026, the Company held its Annual Meeting.

    On GestorLens

    • 4 concentrated managers (-4 this quarter)
    • 208 13F filers
    • 1 13D filings in the last year

    Well-known investors: Stanley Druckenmiller

    GestorLens profile
  • Wesbanco

    WSBC
    • 16:58 ETDividends and buybacksSEC 8-K 8.01

      Dividends and buybacks

      Other events.

      Company headline: “WesBanco Declares Preferred Stock Dividend and Increase in Quarterly Cash Common Dividend”

      From the company's release
      WesBanco, Inc. (Nasdaq: WSBC), a diversified, multi-state bank holding company, announced today that its Board of Directors has approved a 2.6% increase in the quarterly cash dividend to $0.39 per common share from the previous quarterly dividend of $0.38 per common share.

    On GestorLens

    • 1 concentrated managers
    • 357 13F filers
    GestorLens profile
  • Galapagos

    LKFT
    • 16:57 ETOtherSEC 6-K

      Foreign issuer report

      Company announcement.

      Company headline: “Lakefront Creates New Subscription Right Plan”

      From the company's release
      Mechelen, Belgium; November 18, 2026, 22.01 CET; regulated information – Lakefront Biotherapeutics NV (Euronext & NASDAQ: LKFT) announced that its Board of Directors has created 150,000 subscription rights under a new subscription right plan on November 10, 2026.

    On GestorLens

    • 8 concentrated managers (+2 this quarter)
    • 95 13F filers

    Well-known investors: David Einhorn

    GestorLens profile
  • Helmerich & Payne

    HP
    • 16:57 ETEarningsSEC 8-K 2.02

      Results of operations and financial condition

      Company headline: “HELMERICH & PAYNE, INC. ANNOUNCES FISCAL FOURTH QUARTER AND FISCAL 2026 RESULTS”

      From the company's release
      H&P announced consolidated revenue of $1.1 billion, reflecting 6% sequential growth.

    On GestorLens

    • 2 concentrated managers
    • 385 13F filers
    GestorLens profile
  • Walt Disney

    DIS
    • 16:55 ETPlanned insider salesSEC Form 144

      Notice of proposed sale (Form 144)

      Notice of proposed sale: Robert A Iger (officer, director) may sell up to 321,694 shares (~$39.5 million) on or about November 18, 2026.

    On GestorLens

    • 72 concentrated managers (+1 this quarter)
    • 2,985 13F filers

    Well-known investors: Semper Augustus, Viking Global, Giverny Capital, Markel Group

    GestorLens profile
  • The Chemours

    CC
    • 16:52 ETLeadership changesSEC 8-K 5.02

      Departure or appointment of directors or officers

      Company headline: “The Chemours Company Announces Retirement of Kristine Wellman and Appointment of Amy Rocklin as General Counsel”

      From the filing
      On November 18, 2026, The Chemours Company (the “Company”) issued a press release, announcing that Kristine M. Wellman, Senior Vice President, General Counsel & Corporate Secretary, plans to retire from her position, and the Company has selected Amy M. Rocklin to succeed Ms. Wellman as the Company’s Senior Vice President, General Counsel & Corporate Secretary, effective January 4, 2027 (the “Transition Date”).

    On GestorLens

    • 4 concentrated managers (-1 this quarter)
    • 445 13F filers
    • 7 insiders bought in 180 days ($488,649)
    GestorLens profile
  • Antero Midstream

    AM
    • 16:48 ETPlanned insider salesSEC Form 144

      Notice of proposed sale (Form 144)

      Notice of proposed sale: Yvette Schultz (officer) may sell up to 50,000 shares (~$1.0 million) on or about November 18, 2026.

    On GestorLens

    • 12 concentrated managers
    • 517 13F filers
    GestorLens profile
  • SpyGlass Pharma

    SGP2 filings
    • 16:47 ET5%+ stakesSEC Schedule 13D/A

      Change in a 5%+ stake with activist intent

      Kirk Nielsen and 3 related filers updated their stake: 8.9% (2,989,621 shares) (active, 13D) as of November 16, 2026.

      Filed by: Vensana Capital I GP, LLC

      From the filing
      Solely on behalf of, and only to the extent that it relates to, the Reporting Persons, Item 4 of the Original Schedule 13D is hereby amended and supplemented by the addition of the following: The Reporting Persons have previously reserved the right and continue to reserve the right, based on all relevant factors and subject to applicable law or other restrictions…
    • 16:40 ETPlanned insider salesSEC Form 144

      Notice of proposed sale (Form 144)

      Notice of proposed sale: Samsara BioCapital may sell up to 37,166 shares (~$1.2 million, 0.11% of shares outstanding) on or about November 18, 2026.

    On GestorLens

    • 3 concentrated managers (-1 this quarter)
    • 70 13F filers
    • 4 13D filings in the last year
    GestorLens profile
  • Voyager Therapeutics

    VYGR
    • 16:47 ETEarningsSEC 8-K/A 2.02

      Results of operations and financial condition

      Company headline: “Voyager Reports Third Quarter 2026 Financial and Operating Results”

      From the company's release
      Collaboration Revenues: Collaboration revenue was $4.0 million for the third quarter of 2026, compared to $13.4 million for the third quarter of 2025. The decrease was primarily attributable to lower revenue recognized under the Neurocrine collaboration agreement as activities transition beyond the research phase.

    On GestorLens

    • 3 concentrated managers
    • 121 13F filers
    GestorLens profile
  • Royal Gold

    RGLD
    • 16:46 ETLeadership changesSEC 8-K 5.02

      Departure or appointment of directors or officers

      Company headline: “Royal Gold Strengthens Board of Directors with Appointment of Experienced Mining Executive Harry Kenyon-Slaney and Recommendation for Declassification”

      Also: Regulation FD disclosure

      From the filing
      On November 17, 2026, the Board of Directors (the “Board”) of Royal Gold, Inc. (the “Company”) approved an increase in the size of the Board from seven to eight members and appointed Harry Kenyon-Slaney to fill the resulting vacancy, effective immediately.

    On GestorLens

    • 8 concentrated managers
    • 808 13F filers
    GestorLens profile
  • Gen Digital

    GEN
    • 16:45 ETPlanned insider salesSEC Form 144

      Notice of proposed sale (Form 144)

      Notice of proposed sale: Natalie M Derse (officer) may sell up to 72,341 shares (~$2.2 million) on or about November 18, 2026.

    On GestorLens

    • 4 concentrated managers (-1 this quarter)
    • 727 13F filers
    • 1 insider bought in 180 days ($81,180)
    GestorLens profile
  • Figma

    FIG
    • 16:44 ETPlanned insider salesSEC Form 144

      Notice of proposed sale (Form 144)

      Notice of proposed sale: Praveer Melwani (officer) may sell up to 121,562 shares (~$2.2 million) on or about November 18, 2026.

    On GestorLens

    • 3 concentrated managers (-3 this quarter)
    • 396 13F filers
    • 1 13D filings in the last year
    GestorLens profile
  • Markel Group

    MKL
    • 16:41 ETOtherSEC 8-K 8.01

      Other events

      From the filing
      On November 18, 2026, the Board of Directors (the Board) of Markel Group Inc. (the Company) approved a $2.5 billion increase (the "Additional Authorization") to the Company's existing $2.0 billion share repurchase authorization (the "Existing Authorization").

    On GestorLens

    • 26 concentrated managers
    • 905 13F filers

    Well-known investors: Giverny Capital

    GestorLens profile
  • Ondas

    ONDS
    • 16:37 ETOtherSEC 8-K 3.02

      Unregistered sale of equity

      Also: Other events

    On GestorLens

    • 442 13F filers
    GestorLens profile
  • Dropbox

    DBX
    • 16:37 ETPlanned insider salesSEC Form 144

      Notice of proposed sale (Form 144)

      Notice of proposed sale: Ross Tennenbaum (officer) may sell up to 30,576 shares (~$1.0 million) on or about November 18, 2026.

    On GestorLens

    • 477 13F filers
    GestorLens profile
  • Palo Alto Networks

    PANW
    • 16:37 ETEarningsSEC 8-K 2.02

      Results of operations and financial condition

      Fiscal Q1 (ended October 31, 2026) results.

      Company headline: “Palo Alto Networks Reports Fiscal First Quarter 2027 Financial Results”

      Also: Unregistered sale of equity; Regulation FD disclosure; Other events

      From the company's release
      Total revenue for the fiscal first quarter 2027 grew 39% year over year to $3.44 billion.

    On GestorLens

    • 49 concentrated managers (+5 this quarter)
    • 3,073 13F filers

    Well-known investors: Stanley Druckenmiller

    GestorLens profile
  • Pinnacle Financial Partners

    PNFP
    • 16:36 ETOtherSEC 8-K 8.01

      Other events

      From the filing
      On November 18, 2026, Pinnacle Bank (the “Bank”), a wholly-owned subsidiary of Pinnacle Financial Partners, Inc. (the “Company”), issued $600 million aggregate principal amount of its 7.200% Fixed-to-Floating Rate Subordinated Bank Notes due 2038 (the “Subordinated Notes”).

    On GestorLens

    • 11 concentrated managers (+2 this quarter)
    • 698 13F filers
    • 4 insiders bought in 180 days ($2.3M)
    GestorLens profile
  • T1 Energy

    TE
    • 16:35 ETLeadership changesSEC 8-K 5.02

      Departure or appointment of directors or officers

      Also: Other events

      From the filing
      Effective November 12, 2026, the board of directors (the “Board”) of T1 Energy Inc. (the “Company”) appointed Evan Calio, 59, the Company’s current Chief Financial Officer, as the Company’s President.

    On GestorLens

    • 1 concentrated managers
    • 304 13F filers
    • 3 13D filings in the last year

    Well-known investors: Soros Fund

    GestorLens profile
  • Northwest Natural Holding

    NWN
    • 16:35 ETOtherSEC 8-K 8.01

      Other events

      From the filing
      As previously disclosed, on May 4, 2026, SiEnergy Gas, LLC (SiEnergy Gas), Pines Gas, Inc. (Pines Gas), and Pines Gas Development, Inc. (Pines Gas Development) filed a request for a general rate increase (Rate Case) with the Railroad Commission of Texas (RRC).

    On GestorLens

    • 1 concentrated managers
    • 313 13F filers
    GestorLens profile
  • Venture Global

    VG2 filings
    • 16:35 ETPlanned insider salesSEC Form 144

      Notice of proposed sale (Form 144)

      Notice of proposed sale: Keith Larson (officer) may sell up to 789,958 shares (~$9.9 million, 0.14% of shares outstanding) on or about November 18, 2026.

    • 16:34 ETPlanned insider salesSEC Form 144

      Notice of proposed sale (Form 144)

      Notice of proposed sale: Jonathan Thayer (officer) may sell up to 222,222 shares (~$2.8 million) on or about November 18, 2026.

    On GestorLens

    • 12 concentrated managers (+1 this quarter)
    • 381 13F filers
    • 1 insider bought in 180 days ($15,987)
    GestorLens profile
  • AST Spacemobile

    ASTS
    • 16:35 ETOtherSEC 8-K 8.01

      Other events

      From the filing
      On November 18, 2026, AST SpaceMobile, Inc. (the “Company”) filed a prospectus supplement, dated November 17, 2026 (the “2026 Prospectus Supplement”), to the prospectus, dated September 5, 2024, included in the Company’s Registration Statement on Form S-3 (Registration No. 333-281939) (the “Registration Statement”)…

    On GestorLens

    • 4 concentrated managers (-1 this quarter)
    • 683 13F filers
    • 1 insider bought in 180 days ($619,200)
    • 4 13D filings in the last year
    GestorLens profile
  • Interparfums

    IPAR
    • 16:35 ETOtherSEC 8-K 7.01

      Regulation FD disclosure

      Company headline: “INTERPARFUMS, INC. ANNOUNCES FULL YEAR 2027 GUIDANCE”

      From the company's release
      INTERPARFUMS, INC. ANNOUNCES FULL YEAR 2027 GUIDANCE New York, New York, November 18, 2026, Interparfums, Inc. (NASDAQ GS: IPAR) (“Interparfums” or the “Company”) today announced initial guidance for its fiscal year ending December 31, 2027.

    On GestorLens

    • 1 concentrated managers
    • 309 13F filers
    GestorLens profile
  • General Motors

    GM
    • 16:35 ETPlanned insider salesSEC Form 144

      Notice of proposed sale (Form 144)

      Notice of proposed sale: Paul A Jacobson (officer) may sell up to 75,000 shares (~$6.3 million) on or about November 18, 2026.

    On GestorLens

    • 10 concentrated managers (-1 this quarter)
    • 1,565 13F filers
    GestorLens profile
  • Viking Holdings

    VIK
    • 16:34 ETPlanned insider salesSEC Form 144

      Notice of proposed sale (Form 144)

      Notice of proposed sale: Minxuan Zhao (officer) may sell up to 69,700 shares (~$6.6 million) on or about November 18, 2026.

    On GestorLens

    • 12 concentrated managers (+2 this quarter)
    • 604 13F filers

    Well-known investors: Viking Global

    GestorLens profile
  • Medline

    MDLN
    • 16:34 ETDeals and acquisitionsSEC 8-K 1.01

      Entry into a material agreement

      Company headline: “Medline Inc. announces pricing of secondary offering of Class A common stock”

      Also: Other events

      From the filing
      On November 16, 2026, Medline Inc. (the “Company”) and Medline Holdings, LP (“Medline Holdings”) entered into a share and unit repurchase agreement (the “Repurchase Agreement”) with certain entities affiliated with Blackstone Inc., The Carlyle Group Inc., and Hellman & Friedman LLC…

    On GestorLens

    • 12 concentrated managers (+2 this quarter)
    • 415 13F filers
    • 1 insider bought in 180 days ($170,750)

    Well-known investors: Lone Pine, ValueAct, Soros Fund

    GestorLens profile
  • Cisco Systems

    CSCO
    • 16:34 ETPlanned insider salesSEC Form 144

      Notice of proposed sale (Form 144)

      Notice of proposed sale: Charles Robbins (director, officer) may sell up to 94,704 shares (~$9.0 million) on or about November 18, 2026.

    On GestorLens

    • 57 concentrated managers (-2 this quarter)
    • 4,016 13F filers

    Well-known investors: Markel Group

    GestorLens profile
  • BridgeBio Pharma

    BBIO
    • 16:33 ETPlanned insider salesSEC Form 144

      Notice of proposed sale (Form 144)

      Notice of proposed sale: Neil Kumar (director, officer) may sell up to 34,980 shares (~$2.7 million) on or about November 18, 2026.

    On GestorLens

    • 9 concentrated managers (+3 this quarter)
    • 468 13F filers
    • 2 13D filings in the last year

    Well-known investors: Viking Global

    GestorLens profile
  • Antero Resources

    AR
    • 16:33 ETPlanned insider salesSEC Form 144

      Notice of proposed sale (Form 144)

      Notice of proposed sale: Yvette Schultz (officer) may sell up to 30,000 shares (~$1.1 million) on or about November 18, 2026.

    On GestorLens

    • 11 concentrated managers (-1 this quarter)
    • 622 13F filers

    Well-known investors: David Einhorn

    GestorLens profile
  • NXP Semiconductors

    NXPI
    • 16:33 ETOtherSEC 8-K 8.01

      Other events

      From the filing
      The Company and the Issuers intend to use the net proceeds from the offering of the Notes for general corporate purposes, which may include capital expenditures or debt repurchases or repayments.

    On GestorLens

    • 11 concentrated managers
    • 1,245 13F filers

    Well-known investors: Semper Augustus

    GestorLens profile
  • AZUL

    AZUL
    • 16:32 ET5%+ stakesSEC Schedule 13G/A

      Change in a passive 5%+ stake

      BlackBarn Capital Partners and 4 related filers updated their stake: 10.1% (40,791,532 shares) (passive, 13G) as of November 16, 2026.

      Filed by: BlackBarn Capital Partners LP

    On GestorLens

    • 3 concentrated managers
    • 48 13F filers
    • 2 13D filings in the last year

    Well-known investors: Viking Global

    GestorLens profile
  • Torm

    TRMD2 filings
    • 16:31 ETOtherSEC 6-K

      Foreign issuer report

      Company announcement.

      Company headline: “Response to Hafnia’s Intention to Exit its Shareholding in TORM”

      From the company's release
      The Board of TORM plc (“TORM”) (Nasdaq: TRMD or TRMD A) notes the announcement today by Hafnia Limited (“Hafnia”) regarding the proposed distribution of its approximately 19.8% shareholding in TORM to their shareholders.
    • 16:15 ET5%+ stakesSEC Schedule 13D/A

      Change in a 5%+ stake with activist intent

      Hafnia updated its stake: 19.81% (20,356,061 shares) (active, 13D) as of November 17, 2026.

      Filed by: Hafnia Ltd

    On GestorLens

    • 165 13F filers
    • 3 13D filings in the last year

    Well-known investors: Howard Marks

    GestorLens profile
  • Liquidia

    LQDA
    • 16:30 ETLeadership changesSEC 8-K 5.02

      Departure or appointment of directors or officers

      Russell Schundler appointed Chief Strategy Officer and General Counsel, effective November 16, 2026.

      From the filing
      On November 12, 2026, the Board of Directors of Liquidia Corporation, a Delaware corporation (the “Company”), appointed Russell Schundler as the Company’s Chief Strategy Officer and General Counsel, effective November 16, 2026 (the “Effective Date”).

    On GestorLens

    • 6 concentrated managers
    • 304 13F filers
    GestorLens profile
  • Dana

    DAN
    • 16:30 ETOtherSEC 8-K 8.01

      Other events

      From the filing
      On November 6, 2026, Dana Incorporated, a Delaware corporation (the “Company”), announced that it had commenced offers to purchase for cash (collectively, the “Tender Offers”) any and all of the Company’s outstanding (i) 4.250% Senior Notes due 2030 (the “2030 Notes”) and (ii) 4.500% Senior Notes due 2032 (the “2032 Notes” and, together with the 2030 Notes, the “Notes”).

    On GestorLens

    • 3 concentrated managers
    • 344 13F filers

    Well-known investors: Soros Fund

    GestorLens profile
  • Consolidated Edison

    ED
    • 16:30 ETDeals and acquisitionsSEC 8-K 1.01

      Entry into a material agreement

      Also: Other events

      From the filing
      On November 16, 2026, Consolidated Edison, Inc. (“Con Edison”) entered into a forward sale agreement (the “Forward Sale Agreement”) with Bank of America, N.A. (the “Forward Purchaser”) relating to 6,000,000 of Con Edison’s Common Shares ($0.10 par value) (the “Common Shares”).

    On GestorLens

    • 7 concentrated managers (-2 this quarter)
    • 1,392 13F filers
    • 1 insider bought in 180 days ($221)
    GestorLens profile
  • CG Oncology

    CGON2 filings
    • 16:30 ETInsider buyingSEC Form 4 (P)

      Open-market purchase by an insider

      Arthur Kuan (Chief Executive Officer) bought 30,000 shares for $2.4 million (avg. $78.88).

    • 16:30 ETInsider buyingSEC Form 4 (P)

      Open-market purchase by an insider

      Isabel Kalofonos (Chief Commercial Officer) bought 3,751 shares for $299,161 (avg. $79.75).

    On GestorLens

    • 8 concentrated managers (-2 this quarter)
    • 233 13F filers
    • 1 insider bought in 180 days ($24.8M)
    GestorLens profile
  • StandardAero

    SARO
    • 16:29 ETLeadership changesSEC 8-K/A 5.02

      Departure or appointment of directors or officers

      From the filing
      On November 13, 2026, Ms. Ernzen entered into the Transition Agreement, pursuant to which Ms. Ernzen will remain employed until December 31, 2026, unless her employment is terminated earlier by either the Company or her (the “Separation Date”), and Ms. Ernzen has agreed to provide transition services (“Transition Services”) as reasonably requested by the Company until the Separation Date.

    On GestorLens

    • 4 concentrated managers
    • 359 13F filers
    GestorLens profile
  • Merck

    MRK
    • 16:27 ETLeadership changesSEC 8-K 5.02

      Departure or appointment of directors or officers

      Company headline: “Thomas H. Glocer to Retire from Merck Board of Directors in May 2027; Douglas M. Baker, Jr. Appointed Independent Lead Director”

    On GestorLens

    • 73 concentrated managers (+3 this quarter)
    • 3,943 13F filers

    Well-known investors: Semper Augustus

    GestorLens profile
  • Rhythm Pharmaceuticals

    RYTM
    • 16:27 ETPlanned insider salesSEC Form 144

      Notice of proposed sale (Form 144)

      Notice of proposed sale: Joseph J Shulman (officer) may sell up to 45,921 shares (~$5.4 million, 0.07% of shares outstanding) on or about November 18, 2026.

    On GestorLens

    • 10 concentrated managers
    • 332 13F filers

    Well-known investors: Stanley Druckenmiller

    GestorLens profile
  • StoneX Group

    SNEX
    • 16:25 ETEarningsSEC 8-K 2.02

      Results of operations and financial condition

      Fiscal Q4 (ended September 30, 2026) results.

      Company headline: “StoneX Group Inc. Reports Fiscal 2026 Fourth Quarter Financial Results”

      From the company's release
      “We are proud to close out fiscal 2026 with record annual results, highlighted by $2.9 billion in net operating revenues and $525.4 million in net income,” said Philip Smith, the Company’s Chief Executive Officer.

    On GestorLens

    • 4 concentrated managers
    • 480 13F filers
    • 1 insider bought in 180 days ($161,200)
    GestorLens profile
  • Newtekone

    NEWT
    • 16:23 ETOtherSEC 8-K 2.03

      New direct financial obligation

      Also: Other events

    On GestorLens

    • 3 concentrated managers
    • 143 13F filers
    • 4 insiders bought in 180 days ($185,924)
    GestorLens profile
  • Bunge Global

    BG
    • 16:21 ETDeals and acquisitionsSEC 8-K 1.01

      Entry into a material agreement

      Also: New direct financial obligation

      From the filing
      On November 16, 2026, Bunge Limited Finance Corp. (“BLFC”), a wholly owned subsidiary of Bunge Global SA (“Bunge”), entered into a Credit Agreement (the “Term Loan Agreement”), by and among BLFC, as borrower, the lenders from time to time party thereto (the “Lenders”), China Construction Bank Corporation, New York Branch, as administrative agent, and Bank of China Limited, New York Branch, as documentation agent.

    On GestorLens

    • 3 concentrated managers (-2 this quarter)
    • 711 13F filers
    • 1 insider bought in 180 days ($689,050)

    Well-known investors: Soros Fund

    GestorLens profile
  • IMAX

    IMAX
    • 16:20 ETLeadership changesSEC 8-K 5.02

      Departure or appointment of directors or officers

      From the filing
      On November 16, 2026, IMAX Corporation (the “Company”) and Mark Welton, the Company’s President, IMAX Global Theatres, entered into an employment agreement, effective as of January 1, 2027 (the “Agreement”).

    On GestorLens

    • 3 concentrated managers
    • 304 13F filers
    • 1 13D filings in the last year
    GestorLens profile
  • California Water Service Group

    CWT
    • 16:20 ETOtherSEC 8-K 7.01

      Regulation FD disclosure

      Company headline: “Service Group to Become Watermark Utilities, Reflecting Growth Across Western United States”

      Also: Amendments to bylaws or fiscal year

      From the company's release
      California Water Service Group (NYSE: CWT) is marking the conclusion of its centennial year by changing its holding company name to Watermark Utilities, a name that better represents both the company's 100-year legacy and its continued growth as a leading provider of water and wastewater services throughout the western United States.

    On GestorLens

    • 2 concentrated managers (-1 this quarter)
    • 371 13F filers
    GestorLens profile
  • CVR Energy

    CVI
    • 16:19 ETOtherSEC 8-K 7.01

      Regulation FD disclosure

      Company headline: “CVR Energy Announces Offering of Senior Secured Notes Due 2032”

      From the company's release
      CVR Energy, Inc. (the “Company” or “CVR Energy”) (NYSE: CVI) announced today that, subject to market conditions, it intends to offer (the “Offering”) for sale in a private placement pursuant to Rule 144A and Regulation S under the Securities Act of 1933, as amended (the “Securities Act”), $1.25 billion in aggregate principal amount of senior secured notes due 2032 (the “Notes”).

    On GestorLens

    • 2 concentrated managers
    • 266 13F filers
    • 1 13D filings in the last year

    Well-known investors: Carl Icahn

    GestorLens profile
  • GATX

    GATX
    • 16:15 ETDeals and acquisitionsSEC 8-K 1.01

      Entry into a material agreement

      Also: New direct financial obligation

      From the filing
      Indenture with respect to 5.900% Senior Notes due 2032 On November 18, 2026, GABX Leasing LLC (the “Issuer”), a joint venture between GATX Corporation (“GATX”) and Brookfield Infrastructure Partners L.P. and its institutional partners (collectively, “Brookfield”), issued and sold $500,000,000 aggregate principal amount of 5.900% Senior Notes due 2032 (the “Notes”) under an Indenture, dated as of November 18…

    On GestorLens

    • 2 concentrated managers
    • 392 13F filers
    • 1 13D filings in the last year
    GestorLens profile
  • Compass Diversified Holdings

    CODI2 filings
    • 16:15 ETDeals and acquisitionsSEC 8-K 1.01

      Entry into a material agreement

      Also: New direct financial obligation

      From the filing
      As previously disclosed, on November 4, 2026, Compass Group Diversified Holdings LLC (the “Company”) commenced solicitations of consents (the “Consent Solicitations”) from holders of record as of November 2, 2026 of its outstanding 5.250% Senior Notes due 2029 (the “2029 Notes”) and 5.000% Senior Notes due 2032 (the “2032 Notes” and, together with the 2029 Notes…
    • 13:48 ET5%+ stakesSEC Schedule 13G

      New passive 5%+ stake

      HRT Financial reported a stake: 6.5% (5,091,018 shares) (passive, 13G) as of June 30, 2026.

      Filed by: HRT FINANCIAL LP

    On GestorLens

    • 187 13F filers
    • 1 13D filings in the last year

    Well-known investors: Soros Fund

    GestorLens profile
  • Air Products and Chemicals

    APD
    • 16:15 ETOtherSEC 8-K 8.01

      Other events

      Company headline: “Air Products and Chemicals, Inc.”

      From the company's release
      Air Products (NYSE: APD) today announced that it will nominate Carol Williams as an independent director candidate for election to its Board of Directors at the Company’s 2027 Annual Meeting of Shareholders.

    On GestorLens

    • 21 concentrated managers
    • 1,730 13F filers

    Well-known investors: Viking Global, Markel Group

    GestorLens profile
  • S&P Global

    SPGI
    • 16:15 ETDeals and acquisitionsSEC 8-K 1.01

      Entry into a material agreement

      From the filing
      On November 18, 2026, S&P Global Inc. (the “Company”) completed its previously announced public offering (the “Offering”) of $750,000,000 aggregate principal amount of its 5.600% senior notes due 2031, $600,000,000 aggregate principal amount of its 5.800% senior notes due 2034 and $650,000,000 aggregate principal amount of its 6.000% senior notes due 2036 (collectively, the “Notes”)…

    On GestorLens

    • 74 concentrated managers (+3 this quarter)
    • 1,983 13F filers

    Well-known investors: Chris Hohn, Bill Ackman, Semper Augustus, Markel Group and 1 more

    GestorLens profile
  • LPL Financial Holdings

    LPLA
    • 16:15 ETDeals and acquisitionsSEC 8-K 1.01

      Entry into a material agreement

      Also: New direct financial obligation; Other events

      From the filing
      On November 18, 2026, LPL Holdings, Inc. (the “Company”), a wholly-owned subsidiary of LPL Financial Holdings Inc. (the “Guarantor”), completed the issuance and sale of $750,000,000 aggregate principal amount of 5.850% Senior Notes due 2029 (the “Senior Notes”).

    On GestorLens

    • 17 concentrated managers (-1 this quarter)
    • 800 13F filers

    Well-known investors: Lone Pine, Markel Group, Soros Fund

    GestorLens profile
  • Clearway Energy

    CWEN
    • 16:15 ETLeadership changesSEC 8-K 5.02

      Departure or appointment of directors or officers

      From the filing
      As previously disclosed, on November 3, 2026, Clearway Energy, Inc. (the “Company”) received a notice of resignation from Olivier Jouny, informing the Company of his intention to resign from the board of directors (the “Board”) of the Company effective as of the close of business on November 9, 2026.

    On GestorLens

    • 1 concentrated managers
    • 457 13F filers
    • 2 13D filings in the last year
    GestorLens profile
  • LKQ

    LKQ
    • 16:15 ETInsider buyingSEC Form 4 (P)

      Open-market purchase by an insider

      Xavier Urbain (director) bought 26,000 shares for $496,101 (avg. $19.08).

    On GestorLens

    • 12 concentrated managers (-2 this quarter)
    • 491 13F filers
    • 3 insiders bought in 180 days ($792,615)

    Well-known investors: David Einhorn

    GestorLens profile
  • Verisk Analytics

    VRSK
    • 16:13 ETPlanned insider salesSEC Form 144

      Notice of proposed sale (Form 144)

      Notice of proposed sale: Lee Shavel (officer) may sell up to 5,000 shares (~$1.0 million) on or about November 18, 2026.

    On GestorLens

    • 23 concentrated managers (+2 this quarter)
    • 956 13F filers

    Well-known investors: Markel Group, Soros Fund

    GestorLens profile
  • Telesat

    TSAT
    • 16:13 ETOtherSEC 6-K

      Foreign issuer report

      Company announcement.

      Company headline: “Telesat enters into standstill arrangement with GEO lenders allowing Telesat additional time to address upcoming maturities”

      From the company's release
      Telesat Corporation (Nasdaq and TSX: TSAT), one of the world’s largest and most innovative satellite operators, today announced that Telesat and an ad-hoc committee of holders of Telesat GEO Inc.’s term loans, secured notes, and unsecured notes agreed to standstill arrangements, which include that the lenders will not take any enforcement actions through and including January 18, 2027.

    On GestorLens

    • 4 concentrated managers (+1 this quarter)
    • 103 13F filers
    • 2 13D filings in the last year
    GestorLens profile
  • Accelerant Holdings

    ARX
    • 16:12 ETPlanned insider salesSEC Form 144

      Notice of proposed sale (Form 144)

      Notice of proposed sale: Nancy Hasley (director) may sell up to 175,492 shares (~$3.5 million, 0.14% of shares outstanding) on or about November 18, 2026.

    On GestorLens

    • 5 concentrated managers (+1 this quarter)
    • 161 13F filers

    Well-known investors: Tiger Global

    GestorLens profile
  • Snowflake

    SNOW2 filings
    • 16:12 ETPlanned insider salesSEC Form 144

      Notice of proposed sale (Form 144)

      Notice of proposed sale: Frank Slootman (director) may sell up to 225,353 shares (~$62.5 million, 0.06% of shares outstanding) on or about November 18, 2026.

    • 10:00 ETPlanned insider salesSEC Form 144

      Notice of proposed sale (Form 144)

      Notice of proposed sale: Benoit Dageville (officer, director) may sell up to 50,000 shares (~$13.8 million) on or about November 18, 2026.

    On GestorLens

    • 35 concentrated managers (+2 this quarter)
    • 1,630 13F filers

    Well-known investors: Soros Fund

    GestorLens profile
  • Nextpower

    NXT
    • 16:11 ETPlanned insider salesSEC Form 144

      Notice of proposed sale (Form 144)

      Notice of proposed sale: Daniel S Shugar (officer, director) may sell up to 34,253 shares (~$2.8 million) on or about November 18, 2026.

    On GestorLens

    • 6 concentrated managers (-5 this quarter)
    • 646 13F filers

    Well-known investors: Terry Smith

    GestorLens profile
  • Campbell's

    CPB
    • 16:10 ETLeadership changesSEC 8-K 5.02

      Departure or appointment of directors or officers

      Also: Shareholder vote results

      From the filing
      At the Annual Meeting of Shareholders of The Campbell's Company (the "Company"), which was held on November 17, 2026 (the “2026 Annual Meeting”), the Company's shareholders approved the Amended and Restated 2022 Long-Term Incentive Plan (the “Amended and Restated Plan”).

    On GestorLens

    • 6 concentrated managers (+1 this quarter)
    • 581 13F filers
    • 1 insider bought in 180 days ($6,435)

    Well-known investors: Bruce Berkowitz

    GestorLens profile
  • Hewlett Packard Enterprise

    HPE
    • 16:08 ETDeals and acquisitionsSEC 8-K 1.01

      Entry into a material agreement

      Company headline: “SECOND AMENDMENT TO COOPERATION AGREEMENT”

      Also: Departure or appointment of directors or officers; Regulation FD disclosure

      From the filing
      On July 16, 2025, Hewlett Packard Enterprise Company (the "Company") entered into a letter agreement (the "Cooperation Agreement") with Elliott Investment Management L.P., Elliott Associates, L.P., and Elliott International, L.P. (together, "Elliott"), and on May 29, 2026…

    On GestorLens

    • 16 concentrated managers (+4 this quarter)
    • 1,645 13F filers

    Well-known investors: Soros Fund

    GestorLens profile
  • Starwood Property Trust

    STWD
    • 16:07 ETInsider buyingSEC Form 4 (P)

      Open-market purchase by an insider

      Strauss Zelnick (director) bought 172,711 shares for $2.0 million (avg. $11.71).

    On GestorLens

    • 4 concentrated managers (+1 this quarter)
    • 500 13F filers
    • 2 insiders bought in 180 days ($16.7M)
    GestorLens profile
  • Universal Technical Institute

    UTI
    • 16:07 ETEarningsSEC 8-K 2.02

      Results of operations and financial condition

      Company headline: “Universal Technical Institute Reports Fiscal Year 2026 Fourth Quarter and Year-End Results”

      Also: Regulation FD disclosure

      From the company's release
      Full year revenue of $897.0 million in 2026, an increase of 7.4% over the prior year.

    On GestorLens

    • 3 concentrated managers (-2 this quarter)
    • 224 13F filers
    • 1 insider bought in 180 days ($334,710)
    • 1 13D filings in the last year
    GestorLens profile
  • Everpure

    P
    • 16:06 ETEarningsSEC 8-K 2.02

      Results of operations and financial condition

      Fiscal Q3 2027 (ended November 1, 2026) results.

      Company headline: “Everpure Announces Third Quarter Fiscal 2027 Financial Results”

      From the company's release
      Released the Global Data Sovereignty Report 2026, finding that while 90% of surveyed enterprises recognize data sovereignty as a business concern, 64% lack a formal data sovereignty strategy.

    On GestorLens

    • 5 concentrated managers (-4 this quarter)
    • 940 13F filers
    GestorLens profile
  • ACM Research

    ACMR
    • 16:06 ETPlanned insider salesSEC Form 144

      Notice of proposed sale (Form 144)

      Notice of proposed sale: Hui Wang may sell up to 65,000 shares (~$2.8 million, 0.1% of shares outstanding) on or about November 18, 2026.

    On GestorLens

    • 6 concentrated managers
    • 381 13F filers
    GestorLens profile
  • Kulicke and Soffa Industries

    KLIC
    • 16:06 ETEarningsSEC 8-K 2.02

      Results of operations and financial condition

      Q4 2026 results: revenue of $410.3 million; EPS of $1.37 (adjusted: $1.52).

      Company headline: “Co. Regn. No. 199902120H”

      From the company's release
      The Company reported fourth quarter net revenue of $410.3 million, net income of $73.2 million, representing EPS of $1.37 per fully diluted share, and non-GAAP net income of $81.4 million, representing non-GAAP EPS of $1.52 per fully diluted share.

    On GestorLens

    • 5 concentrated managers (-1 this quarter)
    • 438 13F filers
    GestorLens profile
  • Home Depot

    HD
    • 16:06 ETPlanned insider salesSEC Form 144

      Notice of proposed sale (Form 144)

      Notice of proposed sale: Edward P. Decker (officer) may sell up to 19,350 shares (~$6.6 million) on or about November 18, 2026.

    On GestorLens

    • 70 concentrated managers (-3 this quarter)
    • 3,941 13F filers

    Well-known investors: Markel Group, Gates Foundation Trust

    GestorLens profile
  • Nasdaq

    NDAQ
    • 16:05 ETLeadership changesSEC 8-K 5.02

      Departure or appointment of directors or officers

      Michelle L. Daly resigns as Senior Vice President, Controller and Principal Accounting Officer, effective January 1, 2027.

      From the filing
      On November 18, 2026, Nasdaq, Inc. (the “Company”) announced that Michelle L. Daly has resigned as the Company’s Senior Vice President, Controller and Principal Accounting Officer, effective as of January 1, 2027.

    On GestorLens

    • 8 concentrated managers (-1 this quarter)
    • 1,121 13F filers
    GestorLens profile
  • IREN

    IREN
    • 16:04 ET5%+ stakesSEC Schedule 13G

      New passive 5%+ stake

      Jane Street Group and 3 related filers reported a stake: 6.5% (27,353,819 shares) (passive, 13G) as of November 12, 2026.

      Filed by: JANE STREET GROUP, LLC

    On GestorLens

    • 7 concentrated managers (-2 this quarter)
    • 658 13F filers

    Well-known investors: Soros Fund

    GestorLens profile
  • Phathom Pharmaceuticals

    PHAT
    • 16:01 ETLeadership changesSEC 8-K 5.02

      Departure or appointment of directors or officers

      Robert Breedlove resigns as Vice President, Finance and principal accounting officer, effective December 4, 2026.

      From the filing
      On November 12, 2026, Robert Breedlove, Vice President, Finance and principal accounting officer, of Phathom Pharmaceuticals, Inc. (the “Company”) notified the Company of his decision to resign from the Company, effective December 4, 2026.

    On GestorLens

    • 3 concentrated managers (-4 this quarter)
    • 160 13F filers
    • 1 13D filings in the last year
    GestorLens profile
  • Align Technology

    ALGN
    • 16:01 ETLeadership changesSEC 8-K 5.02

      Departure or appointment of directors or officers

      Paul Clancy joins the board, effective December 10, 2026.

      Company headline: “Align Technology Zeno Group”

      From the filing
      On November 17, 2026, the Board of Directors (the “Board”) of Align Technology, Inc. (the “Company”) appointed Paul Clancy, 65, to the Board, effective immediately, and Ian Bell, 56, to the Board, effective December 10, 2026.

    On GestorLens

    • 9 concentrated managers (-1 this quarter)
    • 617 13F filers
    GestorLens profile
  • Par Pacific Holdings

    PARR
    • 16:01 ETOtherSEC 8-K 8.01

      Other events

      Company headline: “Par Pacific Announces Closing of Laramie Energy Sale”

      Also: Regulation FD disclosure

      From the company's release
      Par Pacific Holdings, Inc. (NYSE and NYSE Texas: PARR) (“Par Pacific” or the “Company”) announced that Laramie Energy, LLC (“Laramie”) completed the previously announced sale of substantially all of its oil and gas assets on November 17, 2026, to an affiliate of Enbridge Inc. (the “Transaction”) and, in connection with the Transaction, Laramie redeemed Par Pacific’s 46% non-controlling ownership interest in Laramie.

    On GestorLens

    • 4 concentrated managers (+1 this quarter)
    • 427 13F filers
    GestorLens profile
  • American International Group

    AIG
    • 16:00 ETPlanned insider salesSEC Form 144

      Notice of proposed sale (Form 144)

      Notice of proposed sale: Peter Zaffino may sell up to 221,275 shares (~$17.7 million) on or about November 18, 2026.

    On GestorLens

    • 10 concentrated managers (-1 this quarter)
    • 1,128 13F filers
    • 1 insider bought in 180 days ($10,000)

    Well-known investors: Soros Fund

    GestorLens profile
  • Woodward

    WWD
    • 16:00 ETEarningsSEC 8-K 2.02

      Results of operations and financial condition

      Company headline: “Woodward Reports Record Sales & Earnings for Fiscal Year 2026”

      From the company's release
      “Woodward delivered another year of record sales and earnings, with 22% sales growth and significant margin expansion across both segments, reflecting strong demand and disciplined execution," said Chip Blankenship, Chairman and Chief Executive Officer.

    On GestorLens

    • 16 concentrated managers (-3 this quarter)
    • 700 13F filers
    GestorLens profile
  • ZoomInfo Technologies

    GTM
    • 15:37 ET5%+ stakesSEC Schedule 13D/A

      Change in a 5%+ stake with activist intent

      Jennifer Stier and 1 related filer updated their stake: 7.8% (23,010,148 shares) (active, 13D) as of November 18, 2026.

      Filed by: HighSage Ventures LLC

    On GestorLens

    • 1 concentrated managers
    • 313 13F filers
    • 1 insider bought in 180 days ($99,000)
    • 2 13D filings in the last year
    GestorLens profile
  • Genmab A/S

    GMAB
    • 15:23 ETOtherSEC 6-K

      Foreign issuer report

      Company announcement.

      Company headline: “Grant of Restricted Stock Units and Warrants to Employees in Genmab”

      From the company's release
      Genmab A/S (Nasdaq: GMAB) announced today that the Board of Directors decided to grant 4,993 restricted stock units and 4,607 warrants to employees of the Company and the Company's subsidiaries.

    On GestorLens

    • 6 concentrated managers (+1 this quarter)
    • 331 13F filers
    GestorLens profile
  • Wix.com

    WIX
    • 14:11 ETOtherSEC 6-K

      Foreign issuer report

      Company announcement.

      Company headline: “Only shareholders of record at the close of business on November 23, 2026 are entitled to notice of and to vote at the Meeting.”

      From the company's release
      We cordially invite you to attend the Annual General Meeting of Shareholders of Wix.com Ltd. (the “Meeting”), to be held on December 23, 2026 at 1:30 p.m. (Israel time), at our principal executive offices at the Wix Campus, 5 Yunitsman Street, Building B, 5th Floor, Tel Aviv, Israel, 6936025.

    On GestorLens

    • 3 concentrated managers
    • 240 13F filers

    Well-known investors: ValueAct, Soros Fund

    GestorLens profile
  • Charles Schwab

    SCHW
    • 12:05 ETPlanned insider salesSEC Form 144

      Notice of proposed sale (Form 144)

      Notice of proposed sale: Charles R. Schwab (officer, director) may sell up to 71,400 shares (~$6.6 million) on or about November 18, 2026.

    On GestorLens

    • 46 concentrated managers
    • 2,361 13F filers
    • 1 insider bought in 180 days ($1.8M)

    Well-known investors: Giverny Capital, Markel Group

    GestorLens profile
  • Autoliv

    ALV
    • 12:00 ET5%+ stakesSEC Schedule 13D/A

      Change in a 5%+ stake with activist intent

      Cevian Capital II GP updated its stake: 13.04% (9,319,667 shares) (active, 13D) as of November 16, 2026.

      Filed by: Cevian Capital II GP LTD

    On GestorLens

    • 3 concentrated managers (+1 this quarter)
    • 417 13F filers
    GestorLens profile
  • H World Group

    HTHT2 filings
    • 11:27 ETPlanned insider salesSEC Form 144/A

      Amended notice of proposed sale (Form 144)

      Notice of proposed sale: Hui Jin (affiliate) may sell up to 500,000 shares (~$2.7 million) on or about November 18, 2026.

    • 07:00 ETPlanned insider salesSEC Form 144

      Notice of proposed sale (Form 144)

      Notice of proposed sale: Hui Jin (affiliate) may sell up to 9,362,110 shares (~$46.8 million, 0.3% of shares outstanding) on or about November 18, 2026.

    On GestorLens

    • 7 concentrated managers (-4 this quarter)
    • 256 13F filers
    GestorLens profile
  • Atmus Filtration Technologies

    ATMU
    • 10:32 ETDividends and buybacksSEC 8-K 7.01

      Dividend announcement

      Quarterly dividend of $0.06 per share, payable December 16, 2026 to shareholders of record on December 1, 2026.

      Company headline: “Atmus Filtration Technologies Declares Quarterly Dividend”

      From the filing
      On November 18, 2026, Atmus Filtration Technologies Inc. (the "Company") issued a press release reporting that its Board of Directors declared a quarterly cash dividend in the amount of $0.06 per common share, payable on December 16, 2026, to shareholders of record at the close of business on December 1, 2026.

    On GestorLens

    • 1 concentrated managers (-1 this quarter)
    • 325 13F filers
    • 1 insider bought in 180 days ($99,560)
    GestorLens profile
  • Glaukos

    GKOS2 filings
    • 09:59 ETPlanned insider salesSEC Form 144

      Notice of proposed sale (Form 144)

      Notice of proposed sale: Thomas William Burns (officer, director) may sell up to 180,000 shares (~$44.2 million, 0.3% of shares outstanding) on or about November 18, 2026.

    • 09:45 ETPlanned insider salesSEC Form 144

      Notice of proposed sale (Form 144)

      Notice of proposed sale: Alex R. Thurman (officer) may sell up to 15,000 shares (~$3.7 million) on or about November 18, 2026.

    On GestorLens

    • 6 concentrated managers (+3 this quarter)
    • 422 13F filers
    GestorLens profile
  • The TJX Companies

    TJX
    • 09:19 ETEarningsSEC 8-K 2.02

      Results of operations and financial condition

      Fiscal Q3 (ended October 31, 2026) results: EPS of $1.39 (adjusted: $1.34).

      From the company's release
      Q3 diluted earnings per share of $1.39, up 9% versus last year and above the Company's plan

    On GestorLens

    • 45 concentrated managers (-2 this quarter)
    • 2,619 13F filers

    Well-known investors: Terry Smith

    GestorLens profile
  • Axon Enterprise

    AXON
    • 09:06 ETOtherSEC 8-K 8.01

      Other events

      From the filing
      On November 5, 2026, Axon Enterprise, Inc. (“Axon”) announced the Skydio Investment, an incremental minority investment of approximately $1.2 billion in Skydio, Inc. (“Skydio”), as described in Axon’s Current Report on Form 8-K filed on November 5, 2026 (the “Skydio 8-K”).

    On GestorLens

    • 23 concentrated managers (+4 this quarter)
    • 1,109 13F filers
    GestorLens profile
  • Modine Manufacturing

    MOD
    • 09:00 ETDividends and buybacksSEC 8-K 8.01

      Share buyback

      New share buyback of up to $500 million.

      Company headline: “Welcome and Opening Remarks”

      Also: Regulation FD disclosure

      From the filing
      On November 13, 2026, the Board of Directors (the "Board") of Modexus Solutions, Inc. ("the "Company") authorized a new share repurchase program (the "Share Repurchase Program") that allows the Company to repurchase up to $500 million of its common stock, par value $0.625 per share (the "common stock").

    On GestorLens

    • 12 concentrated managers (+1 this quarter)
    • 563 13F filers

    Well-known investors: David Tepper

    GestorLens profile
  • Expeditors International of Washington

    EXPD
    • 09:00 ETEarningsSEC 8-K 2.02

      Results of operations and financial condition

      Company headline: “EXPD X NYSE |”

      Also: Regulation FD disclosure

      From the company's release
      Expeditors is Going to space FORECASTED GLOBAL SPACE ECONOMY 700B in 2026 1.8T in 2035 Kennedy Space Center, Cape Canaveral Cape Canaveral represents 70% of U.S. launches Exclusive 266,000 sq ft warehouse: Spaceport Logistics Center 17 launch pads across 65 acres Space processing capacity FORECASTED LAUNCHES 190 in 2026 1,000 in 2030

    On GestorLens

    • 11 concentrated managers (+4 this quarter)
    • 1,010 13F filers
    GestorLens profile
  • Progressive

    PGR
    • 09:00 ETOtherSEC 8-K 7.01

      Regulation FD disclosure

      Company headline: “Mayfield Village, Ohio 44143”

      From the company's release
      Progressive offers personal and commercial insurance throughout the United States. Our Personal Lines business writes insurance for personal vehicles (auto and special lines products) and personal property insurance for homeowners and renters.

    On GestorLens

    • 41 concentrated managers (-2 this quarter)
    • 1,805 13F filers

    Well-known investors: Giverny Capital, Markel Group, Bruce Berkowitz, Viking Global and 1 more

    GestorLens profile
  • ACI Worldwide

    ACIW
    • 09:00 ETLeadership changesSEC 8-K 5.02

      Departure or appointment of directors or officers

      Thomas W. Warsop III resigns from the board, effective November 18, 2026. Sara Arrasmith Kuhl appointed Chief Accounting Officer, effective November 18, 2026.

      Company headline: “ACI Worldwide Appoints Robert Leibrock as Interim Chief Executive Officer”

      From the filing
      On November 13, 2026, Thomas W. Warsop III notified the Board of Directors (the “Board”) of ACI Worldwide, Inc. (the “Company”) of his decision to resign as a member of the Board and as Chief Executive Officer and President of the Company, effective November 18, 2026.

    On GestorLens

    • 5 concentrated managers
    • 379 13F filers
    GestorLens profile
  • Quanterix

    QTRX
    • 08:53 ETLeadership changesSEC 8-K 5.02

      Departure or appointment of directors or officers

      Everett Cunningham resigns as President and Chief Executive Officer, effective November 18, 2026.

      Company headline: “Quanterix Announces Leadership Transition Plan”

      Also: Regulation FD disclosure

      From the filing
      On November 18, 2026, Quanterix Corporation (the “Company”) announced that Everett Cunningham has resigned as President and Chief Executive Officer of the Company and as a member of the Company’s Board of Directors (the “Board”), both effective as of November 18, 2026.

    On GestorLens

    • 3 concentrated managers (+1 this quarter)
    • 123 13F filers
    • 2 insiders bought in 180 days ($296,049)
    GestorLens profile
  • Kornit Digital

    KRNT
    • 08:47 ETEarningsSEC 6-K

      Foreign issuer report

      Company announcement.

      Company headline: “Digital Reports Third Quarter 2026 Results”

      From the company's release
      “We delivered a strong third quarter, with revenue of $58.3 million, up nearly 10% year over year and at the high end of our guidance range.

    On GestorLens

    • 6 concentrated managers
    • 137 13F filers
    GestorLens profile
  • Lowe's

    LOW
    • 08:45 ETEarningsSEC 8-K 2.02

      Results of operations and financial condition

      Q3 2026 results: revenue of $22.8 billion; EPS of $2.98.

      Company headline: “For 6:00 a.m. ET Release”

      From the company's release
      Total sales for the quarter were $22.8 billion, compared to $20.8 billion in the prior-year quarter.

    On GestorLens

    • 27 concentrated managers (-4 this quarter)
    • 2,496 13F filers

    Well-known investors: Markel Group

    GestorLens profile
  • Privia Health Group

    PRVA
    • 08:38 ETEarningsSEC 8-K 7.01

      Regulation FD disclosure

      Company headline: “Privia Health Reports Strong Results in the 2025 Performance Year of the Medicare Shared Savings Program”

      From the company's release
      Privia Health Group, Inc. (Nasdaq: PRVA) today announced that its Accountable Care Organizations (ACOs) achieved shared savings of $374.0 million through the Medicare Shared Savings Program (MSSP) for the 2025 performance year, a 59.7% increase from 2024.

    On GestorLens

    • 4 concentrated managers (+1 this quarter)
    • 294 13F filers
    • 1 13D filings in the last year
    GestorLens profile
  • Tempus AI

    TEM
    • 08:30 ETDeals and acquisitionsSEC 8-K 1.01

      Entry into a material agreement

      From the filing
      On November 16, 2026, Tempus AI, Inc. (the “Company”) and AstraZeneca AB (“AstraZeneca”) entered into a Fifth Amendment (the “Amendment”) to the Master Services Agreement, dated November 17, 2021, between the Company and AstraZeneca (as previously amended, the “MSA”).

    On GestorLens

    • 9 concentrated managers (-1 this quarter)
    • 556 13F filers
    GestorLens profile
  • Primo Brands

    PRMB
    • 08:16 ETPlanned insider salesSEC Form 144

      Notice of proposed sale (Form 144)

      Notice of proposed sale: Triton Water Equity Holdings may sell up to 26,366,806 shares (~$614.9 million, 7.29% of shares outstanding) on or about November 18, 2026.

    On GestorLens

    • 15 concentrated managers (+1 this quarter)
    • 397 13F filers
    • 1 insider bought in 180 days ($2M)
    • 1 13D filings in the last year

    Well-known investors: David Einhorn

    GestorLens profile
  • Summit Therapeutics

    SMMT
    • 08:16 ETOtherSEC 8-K 8.01

      Other events

      From the filing
      On November 18, 2026, Summit Therapeutics Inc. issued a press release announcing the planned initiation of the global Phase III HARMONi-10 trial (“HARMONi-10”).

    On GestorLens

    • 7 concentrated managers (+2 this quarter)
    • 294 13F filers
    • 2 insiders bought in 180 days ($52.2M)
    GestorLens profile
  • GeneDx Holdings

    WGS
    • 08:16 ETLeadership changesSEC 8-K 5.02

      Departure or appointment of directors or officers

      Company headline: “Veteran diagnostics and commercial leader, appointed Chief Executive Officer to lead next phase of growth”

      Also: Regulation FD disclosure

      From the filing
      Additionally, on November 15, 2026, the Board appointed Everett Cunningham as CEO of GeneDx, effective as of the Transition Date. The Board also appointed Mr. Cunningham as a Class II director, effective as of the Transition Date, to serve for a term expiring at GeneDx’s 2029 annual meeting of stockholders.

    On GestorLens

    • 6 concentrated managers (-3 this quarter)
    • 217 13F filers
    • 1 insider bought in 180 days ($11.1M)
    • 1 13D filings in the last year
    GestorLens profile
  • Hesai Group

    HSAI
    • 08:15 ETDividends and buybacksSEC 6-K

      Foreign issuer report

      Company announcement.

      Company headline: “Hesai Group Announces US$100 Million Share Repurchase Program”

      From the company's release
      Co-Founder and CEO, said, “The share repurchase program underscores our strong confidence in the Company’s business outlook and reflects our unwavering commitment to maximizing long-term value for our shareholders.

    On GestorLens

    • 5 concentrated managers (-1 this quarter)
    • 131 13F filers
    GestorLens profile
  • Occidental Petroleum

    OXY
    • 08:08 ETOtherSEC 8-K 7.01

      Regulation FD disclosure

      Company headline: “Occidental Announces Cash Tender Offers and Consent Solicitations for Certain of its Senior Notes and Debentures”

      From the company's release
      Occidental (NYSE: OXY) today announced that it has commenced offers to purchase for cash (collectively, the “Tender Offers” and each a “Tender Offer”) its outstanding senior notes and debentures listed in the tables below and Consent Solicitations (as defined below) with respect to each series of senior notes and debentures…

    On GestorLens

    • 14 concentrated managers
    • 1,297 13F filers
    • 1 insider bought in 180 days ($249,853)

    Well-known investors: Berkshire Hathaway

    GestorLens profile
  • Surgery Partners

    SGRY
    • 07:47 ETOtherSEC 8-K 7.01

      Regulation FD disclosure

      Company headline: “Surgery Partners, Inc. Announces Increased”

      From the company's release
      Surgery Partners, Inc. (“Surgery Partners”) (Nasdaq: SGRY) announced today that its indirect wholly owned subsidiary, Surgery Center Holdings, Inc. (the “Issuer”), has amended its previously announced solicitation of consents (the “Consent Solicitation”) from holders (“Holders”) of its outstanding $1,225,000,000 aggregate principal amount of 7.250% Senior Notes due 2032 (CUSIP Nos. 86881W AF9 / U86786 AD9 / U86786…

    On GestorLens

    • 1 concentrated managers (-1 this quarter)
    • 191 13F filers
    • 1 insider bought in 180 days ($161,212)
    • 1 13D filings in the last year

    Well-known investors: Howard Marks

    GestorLens profile
  • Textron

    TXT
    • 07:44 ETDividends and buybacksSEC 8-K 1.01

      Share buyback

      New share buyback of up to 35,000,000 shares.

      Company headline: “Its Industrial Segment to Kingswood Capital Management for $1.2 Billion · Sale”

      Also: Material impairment; Regulation FD disclosure; Other events

      From the filing
      On November 11, 2026, the Board of Directors of Textron authorized the repurchase of up to 35,000,000 shares of Textron's common stock (the "Repurchase Authorization"), which amount is sufficient for the Company to deploy the proceeds of the Transaction to repurchase shares of its common stock as well as to continue Textron's practice of repurchasing shares to offset the impact of dilution from stock-based…

    On GestorLens

    • 2 concentrated managers (-1 this quarter)
    • 741 13F filers
    GestorLens profile
  • Allied Gold

    AAUC
    • 07:35 ETOtherSEC 6-K

      Foreign issuer report

      Company announcement.

      Company headline: “Allied Gold Provides Update on Full Power Availability at Kurmuk, Advances Toward Commercial Production and Progresses Tsenge Areas Toward Development”

      From the company's release
      Following the successful grid connection energization in September, Ethiopian Electric Power, through its contractor, has begun assembling, installing and commissioning the required equipment and materials for the automated grid stabilization system.

    On GestorLens

    • 4 concentrated managers
    • 128 13F filers
    GestorLens profile
  • Albertsons Companies

    ACI
    • 07:34 ETLeadership changesSEC 8-K 5.02

      Departure or appointment of directors or officers

      Company headline: “Albertsons® Companies Announces General Counsel Transition”

      From the filing
      On November 18, 2026, Albertsons Companies, Inc. (the “Company”) announced that Thomas M. Moriarty, Executive Vice President, M&A and Corporate Affairs, and the Company’s General Counsel and Corporate Secretary, would be stepping down from his role that day.

    On GestorLens

    • 4 concentrated managers (+1 this quarter)
    • 452 13F filers
    • 3 insiders bought in 180 days ($2.5M)
    GestorLens profile
  • Golar LNG

    GLNG2 filings
    • 07:32 ETDividends and buybacksSEC 6-K

      Foreign issuer report

      Company announcement.

      Company headline: “Key information relating to the cash dividend to be paid by Golar LNG Limited (Ticker: GLNG)”

      From the company's release
      Reference is made to the third quarter 2026 report released on November 18, 2026. Golar LNG Limited (“Golar”), NASDAQ ticker: GLNG, has declared a total dividend of $0.25 per share to be paid on December 9, 2026.
    • 07:31 ETEarningsSEC 6-K

      Foreign issuer report

      Company announcement.

      Company headline: “Golar LNG Limited Interim results for the period ended September 30, 2026”

      From the company's release
      Golar LNG Limited (“Golar” or “the Company”) reports Q3 2026 net income attributable to Golar of $23 million inclusive of $12 million of non-cash items1, Adjusted EBITDA1 of $56 million and Total Golar Cash1 of $711 million, before proceeds of a recent $500 million senior notes offering and excluding the $600 million revolving credit facility on the FLNG Esperanza.

    On GestorLens

    • 10 concentrated managers
    • 324 13F filers
    GestorLens profile
  • Greif

    GEF
    • 07:31 ETLeadership changesSEC 8-K 5.02

      Departure or appointment of directors or officers

      Company headline: “Greif Announces Planned CFO Succession”

      Also: Regulation FD disclosure

      From the filing
      On November 16, 2026, Lawrence A. Hilsheimer, Executive Vice President and Chief Financial Officer of Greif, Inc. (the “Company”), notified the Company of his decision to conclude his tenure as Executive Vice President and Chief Financial Officer.

    On GestorLens

    • 1 concentrated managers (-1 this quarter)
    • 310 13F filers
    GestorLens profile
  • Global-E Online

    GLBE
    • 07:30 ETOtherSEC 6-K

      Foreign issuer report

      Company headline: “GMV, Revenue and Profit Growth in the Third”

    On GestorLens

    • 13 concentrated managers (+2 this quarter)
    • 244 13F filers

    Well-known investors: Dragoneer

    GestorLens profile
  • Yesway

    YSWY

    On GestorLens

    • 1 concentrated managers
    • 113 13F filers

    Well-known investors: Soros Fund

    GestorLens profile
  • The AES

    AES
    • 07:06 ETDividends and buybacksSEC 8-K 8.01

      Dividends and buybacks

      Other events.

      Company headline: “AES Announces Stub Period Dividend”

      Also: Regulation FD disclosure

      From the company's release
      On November 17, 2026, the Board of Directors of The AES Corporation (NYSE: AES) (the “Company” or “AES”), declared, subject to the consummation of the Company’s previously announced acquisition, a “stub period” dividend of $0.06369 per share, which is equal to $0.00193 per share of Company common stock (which reflects the most recent regular quarterly dividend rate of $0.17595 per share…

    On GestorLens

    • 4 concentrated managers (-2 this quarter)
    • 680 13F filers

    Well-known investors: Soros Fund

    GestorLens profile
  • BellRing Brands

    BRBR
    • 07:01 ETEarningsSEC 8-K 2.02

      Results of operations and financial condition

      Paul A. Rode steps down as Chief Financial Officer, effective December 1, 2026. Travis E. Leonard appointed Chief Financial Officer.

      Company headline: “BellRing Brands Reports Results for the Fourth Quarter and Fiscal Year 2026; Provides Fiscal Year 2027 Outlook”

      Also: Departure or appointment of directors or officers; Regulation FD disclosure

      From the filing
      On November 18, 2026, the Company announced that Paul A. Rode will step down from his role as the Company’s Chief Financial Officer, effective as of December 1, 2026 (the Effective Date"), and depart the Company effective as of February 28, 2027.

    On GestorLens

    • 3 concentrated managers (+1 this quarter)
    • 322 13F filers
    GestorLens profile
  • Lloyds Banking Group

    LYG
    • 06:53 ETOtherSEC 6-K

      Foreign issuer report

      Company announcement.

      Company headline: “Redemption of 5.462% Senior Callable Fixed-to-Fixed”

      From the company's release
      Group plc (the “Group”) announces that it has issued a notice of redemption for the entire outstanding principal amount of its 5.462% Senior Callable Fixed-to-Fixed Rate Notes due 2028 and Senior Callable Floating Rate Notes due 2028 (the “Notes”).

    On GestorLens

    • 2 concentrated managers (+1 this quarter)
    • 616 13F filers
    GestorLens profile
  • Target

    TGT
    • 06:46 ETEarningsSEC 8-K 2.02

      Results of operations and financial condition

      Q3 2026 results: adjusted EPS of $2.65.

      Company headline: “Target Corporation Reports Third Quarter Earnings”

      From the company's release
      The Company reported third quarter GAAP and Adjusted earnings per share (EPS) of $2.65, compared with prior-year GAAP EPS of $1.51 and Adjusted EPS of $1.78.

    On GestorLens

    • 7 concentrated managers (-1 this quarter)
    • 1,997 13F filers
    GestorLens profile
  • Bullish

    BLSH
    • 06:45 ETEarningsSEC 6-K

      Foreign issuer report

      Company announcement.

      Company headline: “Bullish Reports Third Quarter 2026 Results”

      From the company's release
      David Bonanno, CFO: “Our diversified model and cost discipline delivered year-over-year revenue and earnings growth in a challenging market. Subscription, services, and other revenue grew 13% and adjusted EBITDA rose 24% as Bullish attained a 42% margin.”

    On GestorLens

    • 3 concentrated managers (+1 this quarter)
    • 220 13F filers
    • 1 13D filings in the last year
    GestorLens profile
  • Pony AI

    PONY
    • 06:12 ETEarningsSEC 6-K

      Foreign issuer report

      Company announcement.

      Company headline: “Pony AI Inc. Reports Third Quarter 2026…”

      From the company's release
      Dr. Leo Wang, Chief Financial Officer of Pony.ai, commented, “In the third quarter, strong growth in Robotaxi and Robotruck drove a 75.2% year-over-year increase in total revenues, with Robotaxi fare-charging revenues growing by nearly 400% from the prior-year period.

    On GestorLens

    • 5 concentrated managers
    • 155 13F filers

    Well-known investors: Tiger Global, Soros Fund

    GestorLens profile
  • Ecovyst

    ECVT
    • 06:12 ETLeadership changesSEC 8-K 5.02

      Departure or appointment of directors or officers

      Company headline: “Ecovyst Announces Chief Executive Officer Transition and Reaffirms Full-Year 2026 Guidance.”

      Also: Regulation FD disclosure

      From the filing
      On November 18, 2026, the Board of Directors (the “Board”) of Ecovyst Inc. (the “Company”) announced that Kurt J. Bitting ceased serving as the Company’s President and Chief Executive Officer effective as of November 17, 2026.

    On GestorLens

    • 4 concentrated managers (-1 this quarter)
    • 203 13F filers
    • 1 insider bought in 180 days ($249,994)
    GestorLens profile
  • ZTO Express (Cayman)

    ZTO
    • 06:12 ETEarningsSEC 6-K

      Foreign issuer report

      Company announcement.

      Company headline: “Quarter 2026 Unaudited Financial Results”

      From the company's release
      ZTO Express (Cayman) Inc. (NYSE: ZTO and SEHK: 2057), a leading and fast-growing express delivery company in China (“ZTO” or the “Company”), today announced its unaudited financial results for the third quarter ended September 30, 2026[1].

    On GestorLens

    • 3 concentrated managers (+1 this quarter)
    • 199 13F filers
    GestorLens profile
  • Ametek Inc/

    AME

    On GestorLens

    • 18 concentrated managers (+3 this quarter)
    • 1,252 13F filers
    • 1 insider bought in 180 days ($1M)

    Well-known investors: Giverny Capital

    GestorLens profile
  • Taiwan Semiconductor Manufacturing

    TSM
    • 06:03 ETInsider buyingSEC Form 4 (P)

      Open-market purchase by an insider

      Ursula M Burns (director) bought 1,375 shares for $500,039 (avg. $363.66).

    On GestorLens

    • 179 concentrated managers (-1 this quarter)
    • 3,574 13F filers
    • 2 insiders bought in 180 days ($309,780)

    Well-known investors: David Tepper, Coatue, Tiger Global, Viking Global and 4 more

    GestorLens profile
  • Hafnia

    HAFN
    • 06:01 ETEarningsSEC 6-K

      Foreign issuer report

      Company announcement.

      Company headline: “HAFNIA QUARTERLY-FINANCIAL-INFORMATION-Q3 2026 (UNAUDITED)”

      From the company's release
      I have been part of building this company since its beginnings in 2010, and I took over a business with a clear strategy, a strong balance sheet, and an experienced team at sea and ashore.

    On GestorLens

    • 3 concentrated managers
    • 176 13F filers
    GestorLens profile

What each filing is

Form 8-K
The current report of a material event: the company has 4 business days to file it. Each item is a type of event; the label is the one the company chose.
Schedule 13D
Whoever crosses 5% of the shares intending to influence the company (board seats, a sale, a change of strategy) files a 13D within 5 business days. It is the typical activist filing. More in the glossary
Schedule 13G
The form filed by whoever crosses 5% of a company's shares as a passive investor, with no intent to influence it. Mostly filed by large asset managers and index funds. More in the glossary
Form 4
The form directors, officers and 10%+ shareholders use to report every purchase or sale of their own company's shares, within 2 business days. Only open-market purchases (code P) are shown here. More in the glossary
Form 144
The notice an insider or major shareholder files BEFORE selling restricted shares, when the sale exceeds 5,000 shares or $50,000 in three months. It states how many shares they plan to sell and from when: it does not confirm the sale happened (that comes later in a Form 4).

Everything comes from SEC EDGAR, the system where companies file their documents with the SEC.

Source: SEC EDGAR. Text is built with fixed rules from each filing, without artificial intelligence; quotes stay in their original language. Times are New York (ET), with your browser's time next to them.

Filings are grouped by the New York date and time at which the SEC received each document.

Not investment advice. A notice of proposed sale (Form 144) does not confirm that a sale took place.

Follow the investors you care about

Build your list and get what they report by email, if you turn it on. Free, no credit card.

Create free account